OncLive® On Air

Non-Small Cell Lung Cancer

Clinical Trials

Triple Negative Breast Cancer

Immunotherapy

Breast Cancer

Small Cell Lung Cancer

FDA Approval

Chronic Lymphocytic Leukemia

Multiple Myeloma

Antibody Drug Conjugates

Chemotherapy

Oncology

Metastatic Colorectal Cancer

Prostate Cancer

Bladder Cancer

Colorectal Cancer

Surgery

Pembrolizumab

Biomarker Testing

Metastatic Breast Cancer

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers,... more

32 ratings

Publishes	Daily	Episodes	500	Founded	8 years ago
Number of Listeners		Categories	Health & FitnessScience

Listen to this Podcast

Guests Hosts Reviews Talking Points

Latest Episodes

S17 Ep35: KRAS-Directed Therapy Enters a New Era in Pancreatic Cancer: With Zev A. Wainberg, MD

In this episode of OncLive On Air, Zev A. Wainberg, MD, sat down with OncLive to discuss the rapidly evolving landscape of KRAS-directed therapy in pancreatic ductal adenocarcinoma (PDAC), from pan-RAS inhibition to KRAS G12D–specific strategies, and... more

Today • 10 min

S17 Ep34: As CTCL Staging and Treatment Evolves, Treatment-Associated Rash Remains a Crucial Consideration: With Brad Haverkos, MD

In today’s episode, we welcomed Brad Haverkos, MD, to discuss evolving management and treatment adherence strategies in cutaneous T-cell lymphoma (CTCL). Dr Haverkos is an associate professor of medicine-hematology at the University of Colorado in An... more

Yesterday • 13 min

S17 Ep33: Oncology Town Hall: Updates From Berlin: Oral SERDs in HR+/HER2– Metastatic Breast Cancer — What the Latest Data Really Tell Us

In this podcast, experts Hope S. Rugo, MD, FASCO; Fabrice André, MD, PhD; Nadia Harbeck, MD; and Heather McArthur, MD, MPH; discuss updates from the SERENA-6, evERA, PREcoopERA, and TRAK-ER trials of oral selective estrogen receptor degraders (SERDS)... more

15 Jun 2026 • 30 min

S17 Ep32: Previewing Key Myeloma Presentations to Watch at EHA 2026: With Joshua Richter, MD

In today’s episode, we welcomed Joshua Richter, MD, to preview some of the top multiple myeloma presentations anticipated at the 2026 EHA Congress. Richter is an associate professor of medicine in the Division of Hematology and Medical Oncology at th... more

10 Jun 2026 • 10 min • Most popular

Key Facts

Accepts Guests

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)

Two Onc DocsSam and Karine

Oncology Brothers: Practice-Changing Cancer DiscussionsOncology Brothers

Oncology Today with Dr Neil LoveDr. Neil Love

The DailyThe New York Times

Recent Guests

Joshua Richter

Associate Professor of Medicine; Director of Multiple Myeloma at Mount Sinai

Mount Sinai, Tisch Cancer Institute

Episode: S17 Ep32: Previewing Key Myeloma Presentations to Watch at EHA 2026: With Joshua Richter, MD

Manmeet S. Ahluwalia

Oncologist discussing targeted therapies in gliomas

Episode: S17 Ep30: Tumor Board: Clinical Integration of Molecular Profiling in Glioma—Transforming the Use of Targeted Therapy

Ashley S. Margol

Oncologist discussing pediatric glioma therapies

Episode: S17 Ep30: Tumor Board: Clinical Integration of Molecular Profiling in Glioma—Transforming the Use of Targeted Therapy

Anthony Chi

Staff pathologist at MAP Kaiser Permanente

Mid-Atlantic Permanente Medical Group (Kaiser Permanente)

Episode: S17 Ep28: In-House Molecular Testing in NSCLC Improves Turnaround Time, Tissue Stewardship, and Multidisciplinary Coordination: Featuring Anthony Chi, MD; Monica Peravali, MD; and Archana Jadhav, MD

Monica Peravali

Medical oncologist

Kaiser Permanente (Largo, MD)

Archana Jadhav

Medical oncologist

Kaiser Permanente (Tysons, VA)

Meghan Shea

Attending medical oncologist, Beth Israel Deaconess Hospital Boston; ambulatory medical director and disease program leader for medical oncology

Beth Israel Deaconess Medical Center

Episode: S17 Ep27: Advances in Cervical Cancer: Prevention, Immunotherapy, and the Rise of Antibody-Drug Conjugates: With Ursula A. Matulonis, MD; and Meghan E. Shea, MD

Pedram Razavi

MD, PhD; oncologist discussing ESR1 mutation-directed breast cancer management

Memorial Sloan Kettering Cancer Center

Episode: S17 Ep24: Evolving ESR1 Mutation Testing Directions Complicate the Future of Metastatic Breast Cancer Management: With Pedram Razavi, MD, PhD; and Dara S. Ross, MD

Dara S. Ross

MD; oncologist discussing ESR1 mutation-directed breast cancer management

Memorial Sloan Kettering Cancer Center

Episode: S17 Ep24: Evolving ESR1 Mutation Testing Directions Complicate the Future of Metastatic Breast Cancer Management: With Pedram Razavi, MD, PhD; and Dara S. Ross, MD

Hosts

Riley Kandel

Host of OncLive On Air

Aisling Wehner

Host of OncLive On Air

Reviews

4.5 out of 5 stars from 32 ratings

Best option for CME podcasts
Love the content! Easily the best platform for listening to CME and staying updated while on the go. Keep up the great work!
Apple Podcasts
5
Dlshaka
United Statesa year ago
My favorite podcast for oncology
This podcast provides excellent information to anyone who works in the medical field on oncology.
Apple Podcasts
5
Chiliman1986
United States6 years ago

Embed These Reviews on a Website

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Highly relevant for CME and clinical practice updates.

Strong focus on trials and biomarkers; great for sponsor alignment with oncologic education.

Consistently practical and data-driven, though dense for casual listeners.

Clear, credible expert voices with in-depth clinical context.

Top Health & Fitness Podcasts

On Purpose with Jay ShettyiHeartPodcasts

Passion Struck with John R. MilesPassion Struck with John R. Miles

The Dylan Gemelli PodcastDylan Gemelli

Huberman LabScicomm Media

We're Out of TimeRichard Taite

The Dr. Josh Axe ShowDr. Josh Axe

The Dr. John Delony ShowRamsey Network

Untold Stories: Life with a Severe Autoimmune ConditioniHeartPodcasts

Nothing much happens: bedtime stories to help you sleepWellness Loud

Extend Podcast with Darshan Shah, MDDarshan Shah, MD

Talking Points

Recent interactions between the hosts and their guests.

S17 Ep28: In-House Molecular Testing in NSCLC Improves Turnaround Time, Tissue Stewardship, and Multidisciplinary Coordination: Featuring Anthony Chi, MD; Monica Peravali, MD; and Archana Jadhav, MD

Q: What is an effective collaboration model between pathologists, oncologists, and molecular labs in practice?

An integrated workflow with proactive communication among pathologists, oncologists, and IRs, early tissue allocation decisions, and tumor-board reviews helps ensure timely, accurate diagnoses and unified treatment plans.

S17 Ep28: In-House Molecular Testing in NSCLC Improves Turnaround Time, Tissue Stewardship, and Multidisciplinary Coordination: Featuring Anthony Chi, MD; Monica Peravali, MD; and Archana Jadhav, MD

Q: When should comprehensive genomic profiling be initiated in NSCLC, and how do you decide when to send out for external testing?

We perform comprehensive profiling for most NSCLC cases, especially to inform neoadjuvant therapy and immunotherapy decisions; external testing is reserved for complex cases, cancers of unknown origin, or when clinical trials require centralized labs to meet criteria.

S17 Ep27: Advances in Cervical Cancer: Prevention, Immunotherapy, and the Rise of Antibody-Drug Conjugates: With Ursula A. Matulonis, MD; and Meghan E. Shea, MD

Q: Can you talk about what other significant treatment advances have occurred recently besides adding IO and ADCs?

Advances include refining locally advanced treatment approaches, evaluating neoadjuvant chemotherapy with immunotherapy, reducing reliance on invasive radiation techniques through neoadjuvant strategies, and ongoing trials to determine the best combination or sequencing with weekly cisplatin and radiation to improve survival and morbidity.

S17 Ep26: Emerging Targets, Second-Line Standards, and Molecular Subtyping Signal a New Era in SCLC Care: With Jacob Sands, MD

Q: For the oncologists in the community, what is the most important takeaway from your recent work here?

Community oncologists should recognize the expanding trial landscape and the growing array of drugs in development for SCLC, with an emphasis on enrolling patients in biomarker-informed trials and considering local access to trials, including CAR-T and T-cell engager studies, to offer durable responses where traditional cytotoxics may be limited.

S17 Ep26: Emerging Targets, Second-Line Standards, and Molecular Subtyping Signal a New Era in SCLC Care: With Jacob Sands, MD

Q: What were the most compelling biomarker signals you observed here and how do you envision those findings shaping the design of future trials in the space?

Correlates in cell-free DNA and circulating tumor cells appeared with prognosis and progression, suggesting these biomarkers could be incorporated into trial designs for monitoring disease and potentially selecting patients; ongoing work aims to establish practical, clinically actionable uses of liquid biopsy in SCLC, particularly in MRD contexts and longitudinal monitoring.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About OncLive® On Air

What is OncLive® On Air about and what kind of topics does it cover?

A concise, clinician-focused show featuring in-depth conversations with academic oncologists and researchers about cutting-edge cancer care, trial results, and evolving treatment paradigms across thoracic, breast, GI, and gynecologic malignancies. Episodes emphasize biomarker-driven strategies, targeted therapies, and practical workflows for multidisciplinary teams, often discussing real-world implementation, patient impact, and access considerations. Noteworthy strengths include a strong emphasis on data interpretation, up-to-date trial context, and insights from leading cancer centers, making it especially valuable for oncology professionals seeking continuing education, clinical guidance, and context for emerging therapies. Potential lis... more

Where can I find podcast stats for OncLive® On Air?

Rephonic provides a wide range of podcast stats for OncLive® On Air. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to OncLive® On Air and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does OncLive® On Air get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for OncLive® On Air, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for OncLive® On Air?

Rephonic provides comprehensive predictive audience data for OncLive® On Air, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does OncLive® On Air have?

To see how many followers or subscribers OncLive® On Air has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to OncLive® On Air?

These podcasts share a similar audience with OncLive® On Air:

1. ASCO Daily News
2. Two Onc Docs
3. Oncology Brothers: Practice-Changing Cancer Discussions
4. Oncology Today with Dr Neil Love
5. The Daily

How many episodes of OncLive® On Air are there?

OncLive® On Air launched 8 years ago and published 500 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact OncLive® On Air?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for OncLive® On Air?

Rephonic pulls ratings and reviews for OncLive® On Air from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for OncLive® On Air?

Rephonic provides full transcripts for episodes of OncLive® On Air. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on OncLive® On Air?

Recent guests on OncLive® On Air include:

1. Joshua Richter
2. Manmeet S. Ahluwalia
3. Ashley S. Margol
4. Anthony Chi
5. Monica Peravali
6. Archana Jadhav
7. Meghan Shea
8. Pedram Razavi

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days